AIM IMMUNOTECH INC. Marketable Securities, Unrealized Gain (Loss)
AIM IMMUNOTECH INC. (AIM) reported Marketable Securities, Unrealized Gain (Loss) of -$1.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Income Statement › Other Income
us-gaap:MarketableSecuritiesUnrealizedGainLoss · last filed 2026-08-07
- AIM IMMUNOTECH INC. marketable securities, unrealized gain (loss) for the quarter ending 2026-03-31 was -$1.00K, a 103.70% decline year-over-year.
- AIM IMMUNOTECH INC. marketable securities, unrealized gain (loss) for the quarter ending 2025-12-31 was $129.00K, a 84.77% decline year-over-year.
- AIM IMMUNOTECH INC. marketable securities, unrealized gain (loss) for the quarter ending 2025-09-30 was $11.00K.
- AIM IMMUNOTECH INC. marketable securities, unrealized gain (loss) for the quarter ending 2025-06-30 was -$9.00K, a 106.67% decline year-over-year.
- AIM IMMUNOTECH INC. marketable securities, unrealized gain (loss) for fiscal 2025 was $73.00K, a 87.19% decline from fiscal 2024.
- AIM IMMUNOTECH INC. marketable securities, unrealized gain (loss) for fiscal 2024 was $570.00K.
- AIM IMMUNOTECH INC. marketable securities, unrealized gain (loss) for fiscal 2023 was -$376.00K.
- AIM IMMUNOTECH INC. marketable securities, unrealized gain (loss) for fiscal 2022 was -$928.00K.
| Period end | Marketable Securities, Unrealized Gain (Loss) 3 month | Marketable Securities, Unrealized Gain (Loss) 3 month as first filed | Marketable Securities, Unrealized Gain (Loss) 6 month | Marketable Securities, Unrealized Gain (Loss) 6 month as first filed | Marketable Securities, Unrealized Gain (Loss) 9 month | Marketable Securities, Unrealized Gain (Loss) 9 month as first filed | Marketable Securities, Unrealized Gain (Loss) 12 month | Marketable Securities, Unrealized Gain (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | -$1.00K 10-Q · filed 2026-05-15 | $128.00K derived: sum of 2 quarters · filed 2026-05-15 | $139.00K derived: sum of 3 quarters · filed 2026-05-15 | $130.00K derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-12-31 | $129.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $140.00K derived: sum of 2 quarters · filed 2026-03-27 | $131.00K derived: sum of 3 quarters · filed 2026-08-07 | $73.00K 10-K · filed 2026-03-27 | ||||
| 2025-09-30 | $11.00K 10-Q · filed 2025-11-17 | $2.00K derived: sum of 2 quarters · filed 2026-08-07 | -$56.00K 10-Q · filed 2025-11-17 | $876.00K derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-06-30 | -$9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $18.00K 10-Q · filed 2026-08-07 | $85.00K 10-Q · filed 2025-08-14 | $865.00K derived: sum of 3 quarters · filed 2026-08-07 | $806.00K derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2025-03-31 | $27.00K 10-Q · filed 2026-05-15 | -$27.00K 10-Q · filed 2025-05-15 | $874.00K derived: sum of 2 quarters · filed 2026-05-15 | $815.00K derived: sum of 3 quarters · filed 2026-05-15 | $950.00K derived: sum of 4 quarters · filed 2026-05-15 | |||
| 2024-12-31 | $847.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $788.00K derived: sum of 2 quarters · filed 2026-03-27 | $923.00K derived: sum of 3 quarters · filed 2026-03-27 | $570.00K 10-K · filed 2026-03-27 | -$570.00K 10-K · filed 2025-03-27 | |||
| 2024-09-30 | -$59.00K 10-Q · filed 2025-11-17 | $76.00K derived: sum of 2 quarters · filed 2025-11-17 | -$277.00K 10-Q · filed 2025-11-17 | -$192.00K derived: sum of 4 quarters · filed 2025-11-17 | ||||
| 2024-06-30 | $135.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $42.00K 10-Q · filed 2025-08-14 | -$133.00K derived: sum of 3 quarters · filed 2025-08-14 | -$443.00K derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | -$93.00K 10-Q · filed 2025-05-15 | -$268.00K derived: sum of 2 quarters · filed 2025-05-15 | -$578.00K derived: sum of 3 quarters · filed 2025-05-15 | -$672.00K derived: sum of 4 quarters · filed 2025-05-15 | ||||
| 2023-12-31 | -$175.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -$485.00K derived: sum of 2 quarters · filed 2025-03-27 | -$579.00K derived: sum of 3 quarters · filed 2025-03-27 | -$376.00K 10-K · filed 2025-03-27 | ||||
| 2023-09-30 | -$310.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$404.00K derived: sum of 2 quarters · filed 2023-11-14 | -$201.00K 10-Q · filed 2023-11-14 | $639.00K derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2023-06-30 | -$94.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $109.00K 10-Q · filed 2023-08-14 | $949.00K derived: sum of 3 quarters · filed 2023-08-14 | $585.00K derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2023-03-31 | $203.00K 10-Q · filed 2023-05-15 | $1.04M derived: sum of 2 quarters · filed 2023-05-15 | $679.00K derived: sum of 3 quarters · filed 2023-11-14 | $190.00K derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-12-31 | $840.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $476.00K derived: sum of 2 quarters · filed 2023-11-14 | -$13.00K derived: sum of 3 quarters · filed 2023-11-14 | -$928.00K 10-K · filed 2023-03-31 | ||||
| 2022-09-30 | -$364.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$853.00K derived: sum of 2 quarters · filed 2023-11-14 | -$1.77M 10-Q · filed 2023-11-14 | -$1.17M 10-Q · filed 2022-11-14 | -$1.53M derived: sum of 4 quarters · filed 2023-11-14 | |||
| 2022-06-30 | -$489.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$1.40M 10-Q · filed 2023-08-14 | -$1.16M derived: sum of 3 quarters · filed 2023-08-14 | -$1.27M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | -$915.00K 10-Q · filed 2023-05-15 | -$674.00K derived: sum of 2 quarters · filed 2023-05-15 | -$778.00K derived: sum of 3 quarters · filed 2023-05-15 | |||||
| 2021-12-31 | $241.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $137.00K derived: sum of 2 quarters · filed 2023-03-31 | -$88.00K 10-K · filed 2023-03-31 | |||||
| 2021-09-30 | -$104.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$329.00K 10-Q · filed 2022-11-14 | ||||||
| 2021-06-30 | -$225.00K 10-Q · filed 2022-08-15 | |||||||
| 2020-09-30 | -$75.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$12.00K 10-Q · filed 2021-11-15 | ||||||
| 2020-06-30 | $63.00K 10-Q · filed 2021-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |